Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
NuGel by Hudson Therapeutics for Atopic Dermatitis (Atopic Eczema): Likelihood of Approval
NuGel is under clinical development by Hudson Therapeutics and currently in Phase II for Atopic Dermatitis (Atopic Eczema). According to...